References
- The United States Pharmacopeial Convention. General chapter <797> Pharmaceutical compounding—sterile preparations. In: The United States Pharmacopeial Convention, ed. The United States Pharmacopeia, 27th Revision, and the National Formulary, 22nd Edition. Rockville, MD: United States Pharmacopeial Convention; 2004: 2350–2370.
- Cundell AM. Review of the media selection and incubation conditions for the compendial sterility and microbial limit tests. Pharm Forum. 2002; 28(6): 2034–2041.
- Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003; 60(22): 2314–2320.
- Rowe EC, Savage SW, Rutala WA, et al. Economic and microbiologic evaluation of single-dose vial extension for hazardous drugs. J Oncol Pract. 2012; 8(4): e45–e49.
- McMichael DM, Jefferson DM, Carey ET, et al. Utility of the PhaSeal closed system drug transfer device. Am J Pharm Benefits. 2011; 3(1): 9–16.
- Carey ET, Forrey RA, Haughs D, et al. Second look at utilization of a closed-system transfer device (PhaSeal). Am J Pharm Benefits. 2011; 3(6): 311–318.